Wells Fargo’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Wells Fargo’s Portfolio TCBP Stock Details TCBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9	Closed	-$90	–	7381
2024 Q4	$90	Buy	+9	New	+$279	﹤0.01%	6424
2024 Q3	–	Hold	0	–	–	–	6500
2024 Q2	–	Hold	0	–	–	–	6355
2024 Q1	–	Hold	0	–	–	–	6761
2023 Q4	–	Sell	-4	Closed	-$4.51K	–	6661
2023 Q3	$5.59K	Hold	4	–	–	﹤0.01%	5939
2023 Q2	$7.05K	Buy	4 +2	+100%	+$6.42K	﹤0.01%	5996
2023 Q1	$11.2K	Buy	+2	New	+$27.8K	﹤0.01%	5827

Other funds holding TCBP

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Wells Fargo's TCBP Position: Q1 2025 in Review

Wells Fargo sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q1 2025, closing a stake of 9 shares — an estimated $90 sold.

Wells Fargo first reported a position in TCBP in Q1 2023 and held it in 4 quarters. The position peaked at $11.2K in Q1 2023. 2 funds tracked by Wall St. Rank hold TCBP as of Q1 2025.

Wells Fargo reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q1 2025 after selling out during the quarter.
Wells Fargo sold 9 TC BioPharm (Holdings) plc American Depositary Shares shares in Q1 2025, an estimated $90.
Wells Fargo first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q1 2023 and held it in 4 quarters.
Wells Fargo's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $11.2K in Q1 2023.
2 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.